Brief: IRLAB Q3 Operational Profit Swings To Loss Of Sek 23.9 Mln

IRLAB Therapeutics AB

09/11/2022 06:05

Nov 9 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB PUBLISHES INTERIM REPORT FOR THE PERIOD
JANUARY–SEPTEMBER
2022
    * Q3 NET SALES SEK 16.5M (SEK 195.6M)
    * Q3 OPERATIONAL RESULT SEK -23.9M (SEK 121.7 M)

Source text for Eikon:  ID:nMFN14WHrS 
Further company coverage:  IRLABa.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))